Dow Up 0.51% Nasdaq Up 0.24%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
18.95 Up 0.36(1.94%) Nov 21, 4:00PM EST
|After Hours : 19.41 Up 0.46 (2.43%) Nov 21, 4:46PM EST
Prev Close:18.59
Open:18.93
Bid:15.20 x 2000
Ask:N/A
1y Target Est:23.17
Beta:-0.54
Earnings Date:Feb 4 - Feb 9 (Est.)
Day's Range:18.63 - 19.27
52wk Range:8.87 - 20.29
Volume:554,669
Avg Vol (3m):532,078
Market Cap:1.44B
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBIX

Comparison

Symbol% ChgMkt Cap
NBIXUp 1.94%1.44B
ABTUp 0.07%65.97B
LLYUp 0.84%72.05B
PFEUp 0.03%191.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,935.52
Ex-Dividend Date:29-Dec-95

Analysts

Annual EPS Est (Dec-14) :-0.82
Quarterly EPS Est (Dec-14) :-0.25
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neurocrine Biosciences, Inc. discovers, develops, and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback